Oncogenesis: Animal Models

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 21-30 of 45 total displayed.

Past content

Human Cancer Biology
NRH:Quinone Oxidoreductase 2-Deficient Mice Are Highly Susceptible to Radiation-Induced B-Cell Lymphomas

Karim Iskander, Roberto J. Barrios, and Anil K. Jaiswal
Clin. Cancer Res. 2009; 15: 1534-1542. [Abstract] [Full text] [PDF]  

Research Articles
Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu

Amy A. Hakim, Catherine P. Barry, H. John Barnes, Kenneth E. Anderson, James Petitte, Regina Whitaker, Jonathan M. Lancaster, Robert M. Wenham, Donna K. Carver, Jane Turbov, Andrew Berchuck, Levy Kopelovich, and Gustavo C. Rodriguez
Cancer Prevention Research 2009; 2: 114-121. [Abstract] [Full text] [PDF]  

Research Articles
A Short-term Rat Mammary Carcinogenesis Model for the Prevention of Hormonally Responsive and Nonresponsive In situ Carcinomas

Stephan Woditschka, Jill D. Haag, Ruth Sullivan, and Michael N. Gould
Cancer Prevention Research 2009; 2: 153-160. [Abstract] [Full text] [PDF]  

Prevention
Inhibition of Peroxisome Proliferator-Activated Receptor Increases Estrogen Receptor–Dependent Tumor Specification

Yuzhi Yin, Hongyan Yuan, Xiao Zeng, Levy Kopelovich, and Robert I. Glazer
Cancer Res. 2009; 69: 687-694. [Abstract] [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in Apc^Min/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways

Kiyoshi Yamaguchi, Maria Cekanova, Michael F. McEntee, Joo-Heon Yoon, Susan M. Fischer, Ingrid B. Renes, Isabelle Van Seuningen, and Seung Joon Baek
Mol. Cancer Ther. 2008; 7: 2779-2787. [Abstract] [Full text] [PDF]  

Cancer Therapy: Preclinical
Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis

Zhengming Xiong, Soheila Gharagozlou, Isabelita Vengco, Wei Chen, and John R. Ohlfest
Clin. Cancer Res. 2008; 14: 5484-5493. [Abstract] [Full text] [PDF]  

Experimental Therapeutics, Molecular Targets, and Chemical Biology
Chemoprevention and Treatment of Experimental Cowden's Disease by mTOR Inhibition with Rapamycin

Cristiane H. Squarize, Rogerio M. Castilho, and J. Silvio Gutkind
Cancer Res. 2008; 68: 7066-7072. [Abstract] [Full text] [PDF]  

Commentary
The Untapped Potential of Genetically Engineered Mouse Models in Chemoprevention Research: Opportunities and Challenges

Cory Abate-Shen, Powel H. Brown, Nancy H. Colburn, Eugene W. Gerner, Jeffery E. Green, Martin Lipkin, William G. Nelson, and David Threadgill
Cancer Prevention Research 2008; 1: 161-166. [Abstract] [Full text] [PDF]  

Prevention
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth

Dingzhi Wang, Haibin Wang, Wei Ning, Michael G. Backlund, Sudhansu K. Dey, and Raymond N. DuBois
Cancer Res. 2008; 68: 6468-6476. [Abstract] [Full text] [PDF]  

Prevention
The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development

Duo Zheng, Ann M. Bode, Qing Zhao, Yong-Yeon Cho, Feng Zhu, Wei-Ya Ma, and Zigang Dong
Cancer Res. 2008; 68: 3992-3998. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5